![6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds](/docs/US/2019-06-18/US10323042B2/abs.jpg.600x600.jpg)
- Patent Title: 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
-
Application No.: US16074290Application Date: 2017-02-15
-
Publication No.: US10323042B2Publication Date: 2019-06-18
- Inventor: Thomas Allen Chappie , Nandini Chaturbhai Patel , Patrick Robert Verhoest , Christopher John Helal , Simone Sciabola , Erik Alphie LaChapelle , Travis T. Wager , Matthew Merrill Hayward
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agency: Haley Guiliano LLP
- Agent James F. Haley, Jr.
- International Application: PCT/IB2017/050844 WO 20170215
- International Announcement: WO2017/145013 WO 20170831
- Main IPC: H01L51/00
- IPC: H01L51/00 ; C07D498/04 ; C07D519/00
![6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds](/abs-image/US/2019/06/18/US10323042B2/abs.jpg.150x150.jpg)
Abstract:
The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents R1, R2, R3, and R4 are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.
Public/Granted literature
- US20190055262A1 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS Public/Granted day:2019-02-21
Information query
IPC分类:
